
Recro Pharma REPH
Quarterly report 2023-Q3
added 05-16-2026
Recro Pharma Historical Prices 2011-2026 | REPH
Annual Historical Prices Recro Pharma
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.4 | 1.4 | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.4 | 1.4 | 1.4 |
Historical Prices of other stocks in the Drug manufacturers industry
| Issuer | Historical Prices | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Endo International plc
ENDP
|
0.29 | - | - | $ 28.9 M | ||
|
Evoke Pharma
EVOK
|
0.67 | - | - | $ 36.6 M | ||
|
HEXO Corp.
HEXO
|
0.71 | - | 2.45 % | $ 38.1 M | ||
|
Calliditas Therapeutics AB (publ)
CALT
|
19.7 | - | -0.1 % | $ 2.03 B | ||
|
AcelRx Pharmaceuticals
ACRX
|
0.86 | - | 7.5 % | $ 6.35 M | ||
|
DURECT Corporation
DRRX
|
1.21 | - | - | $ 50.1 M | ||
|
Adamis Pharmaceuticals Corporation
ADMP
|
0.12 | - | 0.86 % | $ 117 M | ||
|
Aerie Pharmaceuticals
AERI
|
7.02 | - | - | $ 754 M | ||
|
Cumberland Pharmaceuticals
CPIX
|
5.71 | $ 6.15 | 2.84 % | $ 91.4 M | ||
|
Agile Therapeutics
AGRX
|
0.6 | - | 10.11 % | $ 58.2 M | ||
|
Alimera Sciences
ALIM
|
3.97 | - | - | $ 142 M | ||
|
Cronos Group
CRON
|
1.92 | $ 2.84 | - | $ 1.09 B | ||
|
Athenex
ATNX
|
1.75 | - | -23.39 % | $ 1.76 M | ||
|
Harrow Health
HROW
|
52.6 | $ 35.21 | -0.51 % | $ 1.29 B | ||
|
Avadel Pharmaceuticals plc
AVDL
|
7.54 | - | - | $ 2.06 B | ||
|
Catalent
CTLT
|
60 | - | - | $ 11.5 B | ||
|
Eagle Pharmaceuticals
EGRX
|
26.3 | - | -39.89 % | $ 27.7 M | ||
|
Bausch Health Companies
BHC
|
5.47 | $ 5.36 | -0.92 % | $ 1.99 B | ||
|
Pacira BioSciences
PCRX
|
25.5 | $ 23.22 | -1.94 % | $ 1.07 B | ||
|
Organogenesis Holdings
ORGO
|
2.66 | $ 2.57 | -1.91 % | $ 326 M | ||
|
Canopy Growth Corporation
CGC
|
1.32 | $ 1.09 | -2.68 % | $ 117 M | ||
|
Solid Biosciences
SLDB
|
7.12 | $ 7.34 | 3.82 % | $ 642 M | ||
|
Aurora Cannabis
ACB
|
4.08 | $ 3.6 | -1.91 % | $ 197 M | ||
|
Sonoma Pharmaceuticals
SNOA
|
2.95 | $ 1.14 | 2.7 % | $ 1.41 M | ||
|
Jupiter Wellness
JUPW
|
1.52 | - | - | $ 33.6 M | ||
|
Tilray
TLRY
|
1.93 | $ 5.51 | -2.48 % | $ 3.41 B | ||
|
Lannett Company
LCI
|
0.57 | - | 1.15 % | $ 7.11 M | ||
|
OrganiGram Holdings
OGI
|
1.58 | $ 1.14 | - | $ 109 M | ||
|
Evolus
EOLS
|
4.21 | $ 6.56 | -0.15 % | $ 423 M | ||
|
Sundial Growers
SNDL
|
1.35 | $ 1.48 | -0.67 % | $ 3.37 M | ||
|
Emergent BioSolutions
EBS
|
8.45 | $ 9.12 | -0.65 % | $ 488 M | ||
|
cbdMD
YCBD
|
0.89 | $ 0.79 | -4.12 % | $ 3.18 M | ||
|
Veru
VERU
|
5.8 | $ 2.37 | 2.16 % | $ 34.7 M | ||
|
Neoleukin Therapeutics
NLTX
|
3.49 | - | - | $ 193 M | ||
|
Assertio Holdings
ASRT
|
11.8 | $ 23.44 | - | $ 150 M | ||
|
ProPhase Labs
PRPH
|
8.24 | - | - | $ 5.07 M | ||
|
Radius Health
RDUS
|
8.32 | - | - | $ 1.42 B | ||
|
PetIQ
PETQ
|
13.6 | - | 1.64 % | $ 400 M | ||
|
Relmada Therapeutics
RLMD
|
6.25 | $ 7.21 | -0.55 % | $ 285 M | ||
|
OptiNose
OPTN
|
1.71 | - | - | $ 1.08 B | ||
|
SCYNEXIS
SCYX
|
0.76 | $ 0.71 | -4.12 % | $ 35.5 M | ||
|
PLx Pharma
PLXP
|
5.05 | - | -27.8 % | $ 2.56 M | ||
|
Viatris
VTRS
|
8.69 | $ 16.26 | 0.93 % | $ 18.9 B | ||
|
Zomedica Corp.
ZOM
|
0.14 | - | -0.21 % | $ 98 M | ||
|
Zynerba Pharmaceuticals
ZYNE
|
0.44 | - | - | $ 55.5 M | ||
|
Rockwell Medical
RMTI
|
0.94 | $ 0.74 | -1.8 % | $ 26.6 M | ||
|
Tricida
TCDA
|
7.96 | - | - | $ 3.25 M | ||
|
China Pharma Holdings
CPHI
|
0.64 | $ 0.79 | 3.81 % | $ 3.39 M | ||
|
TherapeuticsMD
TXMD
|
1.99 | $ 2.14 | 1.42 % | $ 24.8 M |